J&J Vaccine: Some CDC Advisors Question Warning’s Strength As Clot Reports Grow, Female Use Drops

Some ACIP members argued woman older than 50 should also be singled out in warning for Johnson & Johnson’s COIVD-19 vaccine and said that people need to be more clearly told they can get alternative vaccines that don’t have this risk.

Johnson and Johnson COVID-19 vaccine
CDC advisors discussed updated safety data on J&J's COVID-19 vaccine on 12 May • Source: Valerio Rosati / Alamy Stock Photo

New updated US data on the rare blood clots seen in people who received Johnson & Johnson’s COVID-19 vaccine, including more reports in older people, caused some members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices to push for stronger warnings on the vaccine at a 12 May meeting.

The CDC’s Vaccine Safety Technical Work Group, which includes ACIP member Grace Lee, is continuing to recommend that the benefits...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet